Form 4 for GALT GALECTIN THERAPEUTICS INC
Accepted 2024-12-26 00:00:00 ET · period of report 2024-12-23 · accession 0001133416-24-000070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-12-26 | 2024-12-23 | GALT | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $0.89 | -56.0K | 897.0K | -6% | -$49.8K |
| DT | 2024-12-26 | 2024-12-23 | GALT | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $0.00 | +56.0K | 953.0K | +6% | $0 |
| DT | 2024-12-26 | 2024-12-23 | GALT | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $0.00 | +56.0K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-23 | S | D | 56,000 | $0.89 | 897,012 | D | — | — | (F2) Shares of common stock sold pursuant to previously disclosed 10b5-1 plan. (F5) Multiple transactions ranging from $0.92 to $0.85 with an average of $0.8859. |
| 2 | Common | Common Stock | 2024-12-23 | M | A | 56,000 | $0.00 | 953,012 | D | — | — | (F1) Shares of common stock acquired for no additional consideration resulting from vesting of Restricted Stock units. |
| 3 | Derivative | Restricted Stock Units | 2024-12-23 | M | A | 56,000 | $0.00 | 0 | D | $0.00 · — to — | 56,000 Common Stock | (F3) Restricted Stock Units disposed upon conversion into shares of common stock pursuant to vesting on December 20, 2024. |